American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
RE
RedHill Biopharma Ltd.
$5.3MMarket cap
23Employees
RDHLNASDAQ
2013IPO
About RedHill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Market cap
- $5.3M
- Market cap
- $5.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 7, 2013
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review RedHill Biopharma Ltd..
Write a review
Explore
Browse all →
